1. The Ratio of GrzB+ − FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic Melanoma
    Giosuè Scognamiglio et al, 2021, Cancers CrossRef
  2. The Influence of Tumor Microenvironment on Immune Escape of Melanoma
    Aleksandra Simiczyjew et al, 2020, International Journal of Molecular Sciences CrossRef
  3. Sex differences in cancer mechanisms
    Joshua B. Rubin et al, 2020, Biology of Sex Differences CrossRef
  4. Prognostic Value of the Platelet-to-Lymphocyte Ratio in Patients With Melanoma: A Meta-Analysis
    Feng Zhang et al, 2020, Frontiers in Oncology CrossRef
  5. Lack of CD8+ T-cell co-localization with Kaposi’s sarcoma-associated herpesvirus infected cells in Kaposi’s sarcoma tumors
    Salum J. Lidenge et al, 2020, Oncotarget CrossRef
  6. Proteomic Implications of Tumoral Infiltrating Lymphocytes in Melanoma: PD-L1, CD4 and CD8 - Short Review
    Nicolau Anca Antonela et al, 2020, ARS Medica Tomitana CrossRef
  7. Oncolytic Virotherapy with Myxoma Virus
    Masmudur M. Rahman et al, 2020, Journal of Clinical Medicine CrossRef
  8. Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
    Vera Petrova et al, 2020, International Journal of Molecular Sciences CrossRef
  9. FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation
    Mirela Cioplea et al, 2020, Journal of Immunology Research CrossRef
  10. Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma
    Vratislav Horak et al, 2019, Genes CrossRef
  11. Mathematical Model for Delayed Responses in Immune Checkpoint Blockades
    Collin Y. Zheng et al, 2021, Bulletin of Mathematical Biology CrossRef
  12. RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study
    Lorenzo Nicolè et al, 2021, Frontiers in Oncology CrossRef
  13. From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
    Lukasz Kuryk et al, 2020, Cancers CrossRef
  14. EVI2B Is a New Prognostic Biomarker in Metastatic Melanoma with IFNgamma Associated Immune Infiltration
    Satoru Yonekura et al, 2021, Cancers CrossRef
  15. Immunostimulatory Effects of Radiotherapy for Local and Systemic Control of Melanoma: A Review
    Junko Takahashi et al, 2020, International Journal of Molecular Sciences CrossRef
  16. Inhibitory Effect of Cuphea aequipetala Extracts on Murine B16F10 Melanoma In Vitro and In Vivo
    Ashanti Concepcion Uscanga-Palomeque et al, 2019, BioMed Research International CrossRef
  17. Pyoderma gangrenosum and suppurative hidradenitis association, overlap or spectrum of the same disease? Case report and discussion
    Gabriela Turcu et al, 2019, Experimental and Therapeutic Medicine CrossRef
  18. Neuroendocrine Factors in Melanoma Pathogenesis
    Cristian Scheau et al, 2021, Cancers CrossRef
  19. Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma
    Mattia Garutti et al, 2021, Cancers CrossRef
  20. Current management of melanoma patients with nodal metastases
    Dale Han et al, 2021, Clinical & Experimental Metastasis CrossRef
  21. Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
    Magdalena Olbryt et al, 2020, International Journal of Molecular Sciences CrossRef